Opinions
Bruce Campbell (2)
Mind Medicine MindMed Inc.
MMED-CN
COMMENT
Dec 08, 2020
The psychedelic space is coming to the forefront for investors who ses this as Cannabis 3.0, but these are not recreational products. Rather, the breakthroughs are coming in medicine to treat PTSD, addictions and anxiety, areas showing promise through psychs. Such companies are building a pharmaceutical platform (drugs to sell to patients). Big pharma isn't in this space yet, but will change over time. He prefers other companies to MMED in this space, but he isn't holding much in this sector yet.
N/A
Stock price when the opinion was issued
0
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
RISKY
This whole area is really quite interesting. The cannabis market was known to be a recreational market but this does not have the same mainstream acceptance as Cannabis. They will be doing research (clinical studies) to come out with new pharmaceuticals to treat mental illness and addiction. It will take multiple years to see the actual drug get to development. If you wanted to have a small piece in your portfolio, you would treat these as lottery tickets.
0
Advertising